Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial

BACKGROUND: LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of CV Outcome Results) results demonstrated cardiovascular benefits for patients with type 2 diabetes mellitus at high cardiovascular risk on standard of care randomized to liraglutide versus placebo. The effect of gluca...

Descripción completa

Detalles Bibliográficos
Autores principales: Mann, Johannes F. E., Fonseca, Vivian, Mosenzon, Ofri, Raz, Itamar, Goldman, Bryan, Idorn, Thomas, von Scholten, Bernt Johan, Poulter, Neil R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296845/
https://www.ncbi.nlm.nih.gov/pubmed/30566006
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296845/
https://www.ncbi.nlm.nih.gov/pubmed/30566006
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036418

Ejemplares similares